Elisa Pasini
Overview
Explore the profile of Elisa Pasini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azarfar G, Sun Y, Pasini E, Sidhu A, Brudno M, Humar A, et al.
Am J Transplant
. 2024 Dec;
PMID: 39643006
The coronavirus disease 2019 pandemic has underscored the importance of vaccines, especially for immunocompromised populations like solid organ transplant recipients, who often have weaker immune responses. The purpose of this...
2.
Pasini E, Baciu C, Angeli M, Arendt B, Pellegrina D, Reimand J, et al.
Int J Hepatol
. 2024 Dec;
2024:5560676.
PMID: 39624175
Background: Metabolic dysfunction-associated steatohepatitis (MASH) has become the leading cause of chronic liver disease, but there has been no approved pharmacotherapy to date. Methods: We used a network analysis approach...
3.
To J, Ghosh S, Zhao X, Pasini E, Fischer S, Sapisochin G, et al.
Hum Genomics
. 2024 Jun;
18(1):58.
PMID: 38840185
Background: Liver transplantation (LT) is offered as a cure for Hepatocellular carcinoma (HCC), however 15-20% develop recurrence post-transplant which tends to be aggressive. In this study, we examined the transcriptome...
4.
Baciu C, Ghosh S, Naimimohasses S, Rahmani A, Pasini E, Naghibzadeh M, et al.
Metabolites
. 2024 May;
14(5).
PMID: 38786731
Graft injury affects over 50% of liver transplant (LT) recipients, but non-invasive biomarkers to diagnose and guide treatment are currently limited. We aimed to develop a biomarker of graft injury...
5.
Pellegrina D, Prayitno K, Azhie A, Pasini E, Baciu C, Fischer S, et al.
Front Endocrinol (Lausanne)
. 2023 May;
14:1111614.
PMID: 37223041
Background: Non-alcoholic steatohepatitis (NASH) has become a leading indication for liver transplantation. However, it often recurs in the graft and can also arise in individuals transplanted for other indications. Post-transplant...
6.
Bhat M, Pasini E, Patel P, Yu J, Baciu C, Kurian S, et al.
Cancer Med
. 2022 Oct;
12(4):5150-5157.
PMID: 36205189
Long-term survival of transplant recipients is significantly impacted by malignancy. We aimed to determine whether calcineurin inhibitor (CNI)-treated recipients converted to and weaned off molecular target of rapamycin inhibitor (mTOR-I)...
7.
Allameh A, Huttmann N, Charlebois E, Katsarou A, Gu W, Gkouvatsos K, et al.
Commun Biol
. 2022 Feb;
5(1):153.
PMID: 35194137
Hemojuvelin (HJV) enhances signaling to the iron hormone hepcidin and its deficiency causes iron overload, a risk factor for hepatocellular carcinoma (HCC). We utilized Hjv mice to dissect mechanisms for...
8.
Bhat M, Pasini E, Pastrello C, Angeli M, Baciu C, Abovsky M, et al.
Front Oncol
. 2021 Dec;
11:777834.
PMID: 34881186
Background: Hepatocellular Carcinoma (HCC) is a sexually dimorphic cancer, with female sex being independently protective against HCC incidence and progression. The aim of our study was to understand the mechanism...
9.
Bhat M, Clotet-Freixas S, Baciu C, Pasini E, Hammad A, Ivanics T, et al.
Clin Proteomics
. 2021 Nov;
18(1):27.
PMID: 34794390
Background And Aims: Liver transplantation (LT) can be offered to patients with Hepatocellular carcinoma (HCC) beyond Milan criteria. However, there are currently limited molecular markers on HCC explant histology to...
10.
Sivaraj S, Copeland J, Malik A, Pasini E, Angeli M, Azhie A, et al.
Clin Transplant
. 2021 Nov;
36(2):e14534.
PMID: 34781411
Long-term survival after Liver Transplantation (LT) is often compromised by infectious and metabolic complications. We aimed to delineate alterations in intestinal microbiome (IM) over time that could contribute to medical...